New drug moves closer to becoming first treatment for Fragile X Syndrome

Retrieved on: 2020-12-11 16:41:15

Tags for this article:

Branches of biology

Clinical medicine

Health

Autism

Neurological disorders

Cognitive disorders

Learning disabilities

Psychiatric diagnosis

Fragile X syndrome

Brain damage

Alzheimer's disease

Click the tags to see associated articles and topics

New drug moves closer to becoming first treatment for Fragile X Syndrome. View article details on hiswai:

Excerpt

Tetra Therapeutics, a wholly owned subsidiary of Shionogi & Co., Ltd., is a clinical stage <b>biotechnology</b> company developing a portfolio of therapeutic ...

Article found on: www.buffalo.edu

View Original Article